These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37666939)

  • 1. Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer.
    Lim YX; Mierzwa ML; Sartor MA; D'Silva NJ
    Oncogene; 2023 Sep; 42(40):2939-2955. PubMed ID: 37666939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review.
    Morand GB; Diaconescu A; Ibrahim I; Lamarche G; Ruas JS; Dalfen J; Hier MP; Alaoui-Jamali MA; Maschietto M; da Silva SD
    Clin Exp Metastasis; 2022 Jun; 39(3):407-416. PubMed ID: 35084607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
    Dalianis T
    Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus-related oropharyngeal cancer.
    Taberna M; Mena M; Pavón MA; Alemany L; Gillison ML; Mesía R
    Ann Oncol; 2017 Oct; 28(10):2386-2398. PubMed ID: 28633362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
    Morand GB; Cardona I; Cruz SBSC; Mlynarek AM; Hier MP; Alaoui-Jamali MA; da Silva SD
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Shinomiya H; Nibu KI
    Int J Clin Oncol; 2023 Aug; 28(8):975-981. PubMed ID: 37093464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
    Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Schrank TP; Lenze N; Landess LP; Hoyle A; Parker J; Lal A; Sheth S; Chera BS; Patel SN; Hackman TG; Major MB; Issaeva N; Yarbrough WG
    Cancer; 2021 Aug; 127(15):2788-2800. PubMed ID: 33819343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.
    Economopoulou P; Kotsantis I; Psyrri A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in HPV-Related Oropharyngeal Cancers.
    Roof L; Yilmaz E
    Curr Treat Options Oncol; 2023 Mar; 24(3):170-183. PubMed ID: 36719604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.